SEC Form 4 · accession 0001628280-26-056875
Cellebrite DI Ltd. · CLBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hogan
Officer — Chief Executive Officer · Director
Period of report
Aug 11, 2026
Accepted (ET)
Aug 13, 2026 · 6:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001854587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares, par value NIS 0.00001 | Aug 11, 2026 | A | 339,484 | $0.00 | A | 930,261 | D | |
| Ordinary shares, par value NIS 0.00001F3 | Aug 12, 2026 | S | 139,713 | $15.3861 | D | 790,548 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on September 19, 2025. The performance-based vesting requirements applicable to such awards were satisfied on August 11, 2026, which represents the date on which the level of performance attained was certified.
- F2Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.